VALYSTR · Stock research
Listed on NasdaqGS. What the market is pricing into Arcutis Biotherapeutics, Inc. (ARQT) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Pharmaceutical Preparations · market value about $4.0B · P/E 144.5 · revenue $464M (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows